Author of The Perimenopause Plan Faye James explains why microdosing a GLP-1 in perimenopause is not recommended.

Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...

Wellness influencer Janelle Rohner reveals she is 'microdosing' GLP-1 medication for weight loss and addresses criticism over ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Health and wellness influencer Janelle Rohner had been documenting her weight loss journey long before she admitted to using ...

After revealing her GLP-1 use, wellness influencer Janelle Rohner says she refunded fans who purchased her classes within the last 11 months ...

Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...